Scientists developed sugar-coated nanoparticles using mannose to cross the blood-brain barrier and target glioblastoma. This experimental therapy, tested in mice, increased survival by 50% and shrunk tumors without harming other organs.
A new trial using immunotherapy drug Ipilimumab (Yervoy) offers hope for glioblastoma patients. The drug enhances the immune system to fight cancer cells. A previous patient had clear scans after treatment.
New computer technique enables more precise glioblastoma biopsies using clinical scans, providing deeper insights into tumor biology and treatment responses. Improves tissue analysis for brain cancers.
